• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Kelly Price

Latest:

The Oncology Care Model: What to Expect in the First Data Feed

Eight months into the Oncology Care Model, find out what participants can expect from the first performance data feed released later this month.


Emmanuel F. Petricoin III, PhD

Latest:

Advancing the Wave of Democratization of Cancer Care

Democratizing the complex field of cancer care is not easy. We are providing patients with key information that their own cancer is unique and needs to be treated as such, but there is a great deal of work to be done in putting that knowledge to work.


Jeffrey Gudin, MD

Latest:

Patients, Pain, and Access to Opioids

Is limiting or discontinuing opioid use in clinical care the answer to addressing the opioid epidemic?



Molly MacDonald

Latest:

The Goldilocks Principle: A Personalized Breast Cancer Treatment That Is "Just Right" for You

Molly MacDonald, the founder and CEO of The Pink Fund, writes about how patients with breast cancer can approach decisions about choosing among disparate treatment protocols.


Mark Heaney

Latest:

MACRA Bonus Article 2: Patient Engagement Strategies for Hospital Value-Based Purchasing Programs

The VBP program contains a variety of measures used to determine payment increases or penalties as shown below.


Halah Flynn

Latest:

How to Talk to Older Women About Their Alcohol Use

According to USC Department of Nursing Professor Benita Jean Walton-Moss, PhD, alcohol abuse is often underdiagnosed and undertreated in older women because it is often mistaken for other conditions related to aging. Her research emphasizes the importance of identifying social determinants that may increase patients' risk of alcohol misuse, and outlines a thoughtful approach when screening female patients as a medical professional or caregiver.


Jim Thomson

Latest:

Driving Value With Innovative Approaches to Colon Cancer Screening

Although national guidelines call for men and women at average risk for colorectal cancer (CRC) to begin screening for the disease at age 50, by some estimates, compliance is a mere 38%.


Cory Gamble, DO

Latest:

Glucose-Lowering Treatment Patterns in Patients With Diabetic Kidney Disease

Real-world treatment of diabetic kidney disease in the United States, based on national-level health care claims and electronic health records data, is inconsistent with the current guidelines.


Brian Chiglinsky, MPP

Latest:

End-of-Life Values and Value-Based Care

An editorial in response to the editor in chief’s December 2021 letter discusses evidence supporting the cost-effectiveness of an innovative advance care planning initiative.


Aaron Friedkin, MD

Latest:

Contributor: In the Shift to Value, We Can’t Afford to Leave Radiology Behind

Radiology needs to be more effectively incorporated into value-based care in order for patients to receive quality treatment for various conditions.


Sakshi Sharma, MS

Latest:

Care Management Improves Total Cost of Care for Patients With Dementia

Compared with usual care, a dementia care management program improved various cost of care and utilization metrics in a Medicare managed care population at 12 months.


Adekunle Oke, MD, DrPH

Latest:

COVID-19 Vaccine Hesitancy and Health Literacy in US Southern States

COVID-19 vaccine hesitancy is not associated with health literacy. Personal perception of threat was associated with reduced vaccine hesitancy.


Mary Shannon, BA

Latest:

Predictors of and Barriers to Receipt of Advance Premium Tax Credits

Few eligible individuals apply for the Advance Premium Tax Credit due to knowledge barriers. Additionally, specific sociodemographic characteristics appear to predict applying status.


Caitlin Crabb, PhD

Latest:

Reply to “Industry-Informed Perspectives on the Benefits of Rideshare-Based Medical Transportation”

The authors of “Rideshare Transportation to Health Care: Evidence From a Medicaid Implementation” respond to a letter to the editor.


Thomas Leist, MD

Latest:

Future of MS Management

Key opinion leaders in MS provide closing thoughts on the future of MS treatment including digital therapeutics, new generics, and pipeline drugs on the horizon.


Kevin U. Stephens, Sr, JD, MD

Latest:

Defining Value Among Treatment Options

Payer decision-makers discuss defining value among agents for unintended pregnancy, uterine fibroids, and endometriosis.


Clara E. Filice, MD, MPH, MHS

Latest:

Experience Incentivizing Reduction of Racial and Ethnic Disparities in a Medicaid Hospital Quality Incentive Program

Construction of a composite measure, use of a summary disparity statistic, and measure selection are key considerations in the design of equity-focused payment programs.


Rebecca Thorsness, PhD

Latest:

Comparison of Mortality Between Medicare Advantage and Traditional Medicare Beneficiaries With Kidney Failure

The risk-adjusted 1-year mortality rate was not different between Medicare Advantage and traditional Medicare beneficiaries with kidney failure who initiated dialysis.


Mona Chitre, PharmD

Latest:

The Promising Future of Alzheimer Disease Treatment

Panelists conclude the discussion with personal insight into the promising future of Alzheimer disease treatment.


John V. Cox, DO, MBA

Latest:

How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care

Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.


Ishani Ganguli, MD, MPH

Latest:

Stopping the Flood: Reducing Harmful Cascades of Care

Reducing cascades while maintaining our commitment to high-quality care requires equipping patients and clinicians with the information, tools, and support to embrace uncertainty.


Peter Bearse, PhD

Latest:

An Evaluation of a Care Coaching and Provider Referral Intervention for Behavioral Health Needs

Care coaching and behavioral health provider referral programs produce long-term savings, reductions in avoidable utilization, and increases in targeted services to treat behavioral health conditions.


Valerie Reese, MEd

Latest:

Eliminating Defects in Value: Turnaround of an MSSP ACO

A health system transformational leadership framework and management system made visible and eliminated defects in value and was associated with reduced annual Medicare expenditures and increased quality between 2017 and 2020.


Smita Rawal, PhD

Latest:

Innovation, Affordability, Access: Alzheimer Disease Drugs and the Inflation Reduction Act

The authors explore the economic impact and accessibility challenges of new Alzheimer disease drugs under the Inflation Reduction Act, with emphasis on Medicare, pricing, and health care equity.


Mary Acri, PhD

Latest:

Predictors of and Barriers to Receipt of Advance Premium Tax Credits

Few eligible individuals apply for the Advance Premium Tax Credit due to knowledge barriers. Additionally, specific sociodemographic characteristics appear to predict applying status.


Kevin Kennedy, BS

Latest:

Association Between Hospital-Insurer Contract Structure and Hospital Performance

Hospital performance measures, such as prices and costs, are associated with hospital-insurer contract types.


Scott C. Howell, DO

Latest:

Population-Based Return on Investment of Deploying Transient Elastography

Deploying vibration-controlled transient elastography/controlled attenuation parameter devices at the population level is a financially advantageous solution to address the epidemic of fatty liver disease.


Soeren Mattke, MD, ScD

Latest:

Association of Wound Healing With Quality and Continuity of Care and Sociodemographic Characteristics

Based on the analysis of electronic health records from 480 clinics, we found that better care quality and continuity are associated with better-than-expected wound healing performance.


Nathaniel Smith, PhD

Latest:

Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California

This analysis demonstrates value and innovation of direct-acting antivirals for the treatment of chronic hepatitis C in the US Kaiser Permanente health system.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.